OraSure Technologies Inc (OSUR)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $249.95M
Last updated: Nov 17, 2026 at 11:05 AM ET
OraSure Technologies Inc (OSUR) Valuation Multiples
OraSure Technologies (OSUR) trades at 2.1x sales and 0.8x book value. Its P/S of 2.1x is above its 5-year median of 1.4x. Its forward P/E is 40.0x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 40.0x |
| Price to sales | 2.1x |
| Price to book | 0.8x |
| PEG | N/A |
| FCF yield | -20.0% |
Historical Medians
Against its 10-year medians, its P/S is 25.0% below 2.8x and its P/B is 46.7% below 1.5x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 2.1x | 1.4x | 2.8x |
| P/B | 0.8x | 0.9x | 1.5x |
Valuation History
Over the 7 of the 10 year ends shown that have a P/E, its P/E ranged from 7.5x in 2023 to 90.3x in 2024. 2024 was the highest of those years.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $2.42 | N/A | 1.5x | 0.5x |
| 2024 | $3.61 | 90.3x | 1.4x | 0.7x |
| 2023 | $8.20 | 7.5x | 1.5x | 1.4x |
| 2022 | $4.82 | 28.4x | 0.9x | 1.0x |
| 2021 | $8.69 | N/A | 2.7x | 1.6x |
| 2020 | $10.59 | N/A | 4.2x | 1.9x |
| 2019 | $8.03 | 57.4x | 3.2x | 1.6x |
| 2018 | $11.68 | 22.9x | 3.9x | 2.6x |
| 2017 | $18.86 | 53.9x | 6.7x | 4.6x |
| 2016 | $8.78 | 25.1x | 3.8x | 2.7x |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About OSUR
What is OSUR's forward P/E ratio?
OraSure Technologies has a forward P/E ratio of 40.0x.
Is OSUR stock overvalued?
GNG's valuation label for OSUR is Fairly valued.
What is OSUR's price to sales ratio?
OraSure Technologies has a price to sales ratio of 2.1x.
OSUR pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts